168 related articles for article (PubMed ID: 30744470)
1. Loss of CD169
Topf MC; Harshyne L; Tuluc M; Mardekian S; Vimawala S; Cognetti DM; Curry JM; Rodeck U; Luginbuhl A
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):67-73. PubMed ID: 30744470
[TBL] [Abstract][Full Text] [Related]
2. Reduced number of CD169
Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
5. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
[TBL] [Abstract][Full Text] [Related]
6. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
[TBL] [Abstract][Full Text] [Related]
7. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma.
Scherpelz KP; Wong AC; Lingen MW; Taxy JB; Cipriani NA
Histopathology; 2019 Jan; 74(2):321-331. PubMed ID: 30144145
[TBL] [Abstract][Full Text] [Related]
8. CD169
Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
[TBL] [Abstract][Full Text] [Related]
9. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes.
Topf MC; Tuluc M; Harshyne LA; Luginbuhl A
J Immunother Cancer; 2017 Jul; 5(1):60. PubMed ID: 28716144
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
[TBL] [Abstract][Full Text] [Related]
13. High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.
Takeya H; Shiota T; Yagi T; Ohnishi K; Baba Y; Miyasato Y; Kiyozumi Y; Yoshida N; Takeya M; Baba H; Komohara Y
Pathol Int; 2018 Dec; 68(12):685-693. PubMed ID: 30516869
[TBL] [Abstract][Full Text] [Related]
14. Co-localization of CD169
Björk Gunnarsdottir F; Auoja N; Bendahl PO; Rydén L; Fernö M; Leandersson K
Oncoimmunology; 2020 Nov; 9(1):1848067. PubMed ID: 33299660
[TBL] [Abstract][Full Text] [Related]
15. Melanoma growth and lymph node metastasis is independent of host CD169 expression.
Muhsin-Sharafaldine MR; Saunderson SC; Dunn AC; McLellan AD
Biochem Biophys Res Commun; 2017 May; 486(4):965-970. PubMed ID: 28359758
[TBL] [Abstract][Full Text] [Related]
16. Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activation.
Fujiwara Y; Saito Y; Shiota T; Cheng P; Ikeda T; Ohnishi K; Takeya M; Komohara Y
J Clin Exp Hematop; 2018; 58(1):17-23. PubMed ID: 29553092
[TBL] [Abstract][Full Text] [Related]
17. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi S; Kawahara K; Fujiwara Y; Ohnishi K; Pan C; Yano H; Hirosue A; Nagata M; Hirayama M; Sakata J; Nakashima H; Arita H; Yamana K; Gohara S; Nagao Y; Maeshiro M; Iwamoto A; Hirayama M; Yoshida R; Komohara Y; Nakayama H
Cancer Immunol Immunother; 2022 Sep; 71(9):2127-2139. PubMed ID: 35044489
[TBL] [Abstract][Full Text] [Related]
18. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status.
Maxwell JH; Ferris RL; Gooding W; Cunningham D; Mehta V; Kim S; Myers EN; Johnson J; Chiosea S
Cancer; 2013 Sep; 119(18):3302-8. PubMed ID: 23797868
[TBL] [Abstract][Full Text] [Related]
19. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
20. Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes.
Gray EE; Friend S; Suzuki K; Phan TG; Cyster JG
PLoS One; 2012; 7(6):e38258. PubMed ID: 22675532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]